The gastrointestinal (GI) tract is a continuous tube that processes food, absorbs nutrients, and eliminates waste. Its complex anatomy and physiology are essential for maintaining overall health.
The GI tract can be divided into two major regions: the upper GI tract (mouth, pharynx, esophagus, and stomach) and the lower GI tract (small intestine, large intestine, rectum, and anus). Accessory organs the liver, gallbladder, and pancreas contribute enzymes, bile, and other secretions that aid digestion.
The esophagus is a muscular tube that transports food to the stomach via peristaltic waves. The lower esophageal sphincter (LES) prevents reflux of gastric contents.
The stomach acts as a reservoir and mixer. Gastric glands produce hydrochloric acid (HCl) and pepsinogen, which converts to pepsin for protein digestion. Mucus protects the lining from acid damage.
Consisting of the duodenum, jejunum, and ileum, the small intestine is the primary site of nutrient absorption.
| Segment | Key Functions |
|---|---|
| Duodenum | Receives chyme, bile, and pancreatic enzymes; neutralizes acid. |
| Jejunum | Absorbs carbs, proteins, lipids, vitamins, and minerals. |
| Ileum | Absorbs bile salts, vitamin B12, and remaining nutrients. |
The colon reabsorbs water and electrolytes, forming solid stool. It also houses a large microbial community that ferments undigested carbohydrates, producing shortchain fatty acids vital for colonic health.
These structures store feces until defecation. Internal and external sphincters coordinate voluntary and involuntary control of stool passage.
Failure of the LES allows acid to flow back into the esophagus, causing heartburn and potential esophagitis.
Disruption of the gastric mucosal barrieroften due to Helicobacter pylori infection or NSAID useleads to ulcer formation.
Includes Crohns disease and ulcerative colitis, characterized by chronic inflammation of the intestinal wall, abdominal pain, and diarrhea.
A functional disorder causing abdominal discomfort, bloating, and altered bowel habits without detectable structural abnormalities.
Most common malignancy of the GI tract; screening colonoscopy is recommended starting at age 45 for averagerisk adults.
Advances in microbiome science, personalized nutrition, and minimally invasive endoscopic techniques are reshaping how clinicians diagnose and treat GI diseases. Emerging therapies such as fecal microbiota transplantation (FMT) and genetargeted drugs hold promise for conditions once considered untreatable.
